Monday, April 1, 2019

MissionIRNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries Enters $11 Million Supply Contract for CBD Isolate Powder

Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) today announced that it has executed a one-year supply and processing agreement to produce 99 percent pure CBD (no THC) isolate. The company expects to begin shipping under the contract this month and continue in equal amounts through March 2020. “The Khrysos Industries business model is multi-dimensional, and we are just now starting to fully leverage the capabilities of our extraction systems, end to end processing platform, and the capabilities of INX Labs,” YGYI President and CFO Dave Briskie said in the news release. “We anticipate gearing up our production capabilities across the platform as we move through 2019.”
To view the full press release, visit http://ibn.fm/cU1El
About Youngevity International Inc.
Youngevity International Inc., an emerging conglomerate operating in three distinct business segments including a vertically integrated coffee enterprise, a vertically integrated hemp-based product development enterprise including end-to-end processing, and a direct-selling enterprise that consists of an expanding portfolio of consumer brands developed with its in-house product development team and distributed by traditional and nontraditional channels, including a multi-country, direct-selling network. For more information, visit the company’s website at www.YGYI.com
NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html